Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Investing Activities (2021 - 2025)

P3 Health Partners (PIII) has disclosed Cash from Investing Activities for 5 consecutive years, with -$119000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities fell 100.79% year-over-year to -$119000.0, compared with a TTM value of -$544000.0 through Sep 2025, down 103.74%, and an annual FY2024 reading of $14.5 million, up 895.02% over the prior year.
  • Cash from Investing Activities was -$119000.0 for Q3 2025 at P3 Health Partners, down from $50000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $15.0 million in Q3 2024 and bottomed at -$6.4 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$150000.0, with a median of -$464000.0 recorded in 2023.
  • The sharpest move saw Cash from Investing Activities skyrocketed 75.02% in 2022, then tumbled 100.79% in 2025.
  • Year by year, Cash from Investing Activities stood at -$324833.0 in 2021, then surged by 115.39% to $50000.0 in 2022, then crashed by 1028.0% to -$464000.0 in 2023, then decreased by 2.37% to -$475000.0 in 2024, then skyrocketed by 74.95% to -$119000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for PIII at -$119000.0 in Q3 2025, $50000.0 in Q2 2025, and -$475000.0 in Q4 2024.